TickerFactsScreenerDevelopers

CRISPR Therapeutics AG (CRSP) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$6.63M2015: -$25.73M2016: -$68.13M2017: -$64.65M2018: -$158.94M2019: $46.74M2020: -$354.44M2021: $373.53M2022: -$673.16M2023: -$222.54M2024: -$466.57M2025: -$664.57M-$664.57M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$664.57M-42.4%
2024-$466.57M-109.7%
2023-$222.54M+66.9%
2022-$673.16M-280.2%
2021$373.53M+205.4%
2020-$354.44M-858.3%
2019$46.74M+129.4%
2018-$158.94M-145.9%
2017-$64.65M+5.1%
2016-$68.13M-164.8%
2015-$25.73M-288.2%
2014-$6.63M—